Loading organizations...
Loading organizations...
Key people at 2Morrow, Inc..
Based in Kirkland, Washington, 2Morrow, Inc. is a digital health company that develops smartphone-based behavioral intervention programs for smoking cessation, weight management, and chronic pain. The enterprise operates a business-to-business-to-consumer software-as-a-service model, utilizing Acceptance and Commitment Therapy to deliver digital therapeutics to state health departments, corporate employers, and health plans. These organizations sponsor the wellness applications for their populations to help individuals navigate various behavioral health challenges and improve overall wellbeing. Operating with an estimated headcount of under 50 employees, the firm has secured over $3 million in federal Small Business Innovation Research grant funding to support its ongoing clinical development. The organization collaborates with the Fred Hutchinson Cancer Research Center for clinical research and is guided by board members including Tamara StClaire and investor director Eric Larsen. The digital therapeutics company was founded in 2011 by Jo Masterson and Brandon Masterson.
Key people at 2Morrow, Inc..
2Morrow, Inc. is a digital health company that develops evidence-based mobile programs for behavior change, focusing on wellness areas like smoking cessation, chronic pain management, and mental health support such as grief.[1][5][6] It serves large employers, states, health plans, and individuals by delivering smartphone-based therapeutics that combine behavioral science with technology, helping over half a million users through brief, bundled programs emphasizing valued action and coaching.[1][5] With around 17-32 employees and $1 million in annual revenue, 2Morrow stands out for its research rigor, including over 20 studies and a Phase III clinical trial, positioning it as a leader in digital therapeutics recognized among the top 20 innovative companies of 2025.[1][6]
The company solves accessibility barriers in behavioral health by offering scalable, clinically validated apps that promote lasting change without requiring in-person care, bundling programs for interconnected behaviors like tobacco use and stress.[5] Growth momentum includes NIH grants, peer-reviewed publications, and pandemic-driven demand that made 2020 its best year, with expansions into pain and grief programs.[6]
Founded in 2011 (with some sources noting 2012), 2Morrow was co-founded by Jo Masterson (CEO) and Brandon Masterson (COO/CTO, original founder)—a nurse and a medical device engineer—who pioneered mobile behavior change before "digital health" was mainstream.[1][3][6] Brandon, with prior experience in digital media, e-commerce, and medical devices, drove the vision of usability for users and sponsors, while Jo brought healthcare expertise; they co-founded as partners, blending personal and professional commitment.[3][6]
The idea emerged from recognizing smartphones' potential to democratize behavioral science for chronic issues like smoking, leading to early traction via evidence-building, including a Phase III trial for tobacco cessation involving 2,400 participants and 12+ publications.[1][6] Pivotal moments include securing NIH grants for pain programs and capitalizing on 2020's remote health surge with a grief program, solidifying its research-first DNA.[6]
2Morrow rides the digital therapeutics (DTx) wave, addressing chronic behavioral health gaps amid rising demand for remote, scalable solutions post-pandemic.[6] Timing aligns with mHealth growth, where employers and health plans seek cost-effective alternatives to traditional care for issues like tobacco (affecting millions) and pain, amplified by evidence mandates from payers.[1][5][6]
Market forces favor it: smartphone penetration enables anytime access, while regulatory progress in DTx (e.g., FDA interest) rewards clinical validation, giving 2Morrow an edge over less-studied competitors.[1][6] It influences the ecosystem by setting evidence standards—via trials and publications—pushing the industry toward outcomes-based models and bundled interventions, benefiting startups in wellness tech.[4][5]
2Morrow is poised for expansion in DTx, leveraging 2025 recognition and partnerships to scale beyond tobacco into pain, mental health, and bundled wellness suites amid payer adoption of evidence-based apps.[6] Trends like AI-enhanced personalization, global mHealth growth, and chronic disease burdens will shape its path, potentially via acquisitions or FDA-cleared status.
Its influence may evolve by inspiring values-focused design in digital health, amplifying impact as remote care normalizes—ultimately helping millions act on what matters, as its mission promises.[5][7]
